Kramer Robin bought BIIB
January 29, 2024 · Form 4 insider transaction
Kramer Robin bought 914 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
914
Price
$0.00
Total value
N/A
InsiderKramer Robin
Role—
CompanyBiogen Inc. (BIIB)
SecurityPerformance Stock Unit
Transaction codeA: Grant or award
Transaction dateJanuary 29, 2024
Filing dateJanuary 31, 2024
Shares owned after914
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024.